ZN33B_HUMAN - dbPTM
ZN33B_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID ZN33B_HUMAN
UniProt AC Q06732
Protein Name Zinc finger protein 33B
Gene Name ZNF33B
Organism Homo sapiens (Human).
Sequence Length 778
Subcellular Localization Nucleus .
Protein Description May be involved in transcriptional regulation..
Protein Sequence MNKVDQKFQGSVSFKDVTVGFTQEEWQHLDPSQRALYRDVMLENYSNLVSVGYCAHKPEVIFRLEQGEEPWRLEEEFPSQSFPEVWTADHLKERSQENQSKHLWEVVFINNEMLTKEQGNVIGIPFNMDVSSFPSRKMFCQYDSRGMSFNTVSELVISKINYLGKKSDEFNACGKLLLNIKHDETHTREKNEVLKNRNTLSHRENTLQHEKIQTLDHNFEYSICQETLLEKAVFNTRKRENAEENNCDYNEFGRTFCDSSSLLFHQIPPSKDSHYEFSDCEKFLCVKSTLSKHDGVPVKHYDCGESGNNFRRKLCLSQLQKGDKGEKHFECNECGKAFWEKSHLTRHQRVHTGEKHFQCNQCGKTFWEKSNLTKHQRSHTGEKPFECNECGKAFSHKSALTLHQRTHTGEKPYQCNACGKTFYQKSDLTKHQRTHTGQKPYECYECGKSFCMNSHLTVHQRTHTGEKPFECLECGKSFCQKSHLTQHQRTHIGDKPYECNACGKTFYHKSVLTRHQIIHTGLKPYECYECGKTFCLKSDLTIHQRTHTGEKPFACPECGKFFSHKSTLSQHYRTHTGEKPYECHECGKIFYNKSYLTKHNRTHTGEKPYECNECGKTFCQKSQLTQHQRIHIGEKPYECNECGKAFCHKSALIVHQRTHTQEKPYKCNECGKSFCVKSGLILHERKHTGEKPYECNECGKSFSHKSSLTVHHRAHTGEKSCQCNECGKIFYRKSDLAKHQRSHTGEKPYECNTCRKTFSQKSNLIVHQRTHIGEKPYE
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
13PhosphorylationQKFQGSVSFKDVTVG
HHHCCCEEEEEEEEE
28.4224719451
18PhosphorylationSVSFKDVTVGFTQEE
CEEEEEEEEEECHHH
25.6625002506
22PhosphorylationKDVTVGFTQEEWQHL
EEEEEEECHHHHHHC
29.1925002506
32PhosphorylationEWQHLDPSQRALYRD
HHHHCCHHHHHHHHH
31.7825002506
167PhosphorylationINYLGKKSDEFNACG
HHHCCCCCHHCCCHH
45.9528555341
173UbiquitinationKSDEFNACGKLLLNI
CCHHCCCHHHHHHHC
5.32-
181SumoylationGKLLLNIKHDETHTR
HHHHHHCCCCCCCHH
43.8828112733
202UbiquitinationKNRNTLSHRENTLQH
HCCHHCCHHHHHHHH
44.16-
287UbiquitinationCEKFLCVKSTLSKHD
CCEEEEEHHHHCCCC
36.4029967540
294UbiquitinationKSTLSKHDGVPVKHY
HHHHCCCCCCEECCC
64.62-
321SumoylationLCLSQLQKGDKGEKH
HHHHHHHCCCCCCCC
77.12-
328SumoylationKGDKGEKHFECNECG
CCCCCCCCEEECHHH
21.31-
341SumoylationCGKAFWEKSHLTRHQ
HHHHHHHHHCCCHHC
33.50-
343UbiquitinationKAFWEKSHLTRHQRV
HHHHHHHCCCHHCCC
42.14-
348UbiquitinationKSHLTRHQRVHTGEK
HHCCCHHCCCCCCCC
45.89-
348SumoylationKSHLTRHQRVHTGEK
HHCCCHHCCCCCCCC
45.89-
355AcetylationQRVHTGEKHFQCNQC
CCCCCCCCEEEECCC
51.5720167786
362AcetylationKHFQCNQCGKTFWEK
CEEEECCCCCCHHHH
3.62-
364AcetylationFQCNQCGKTFWEKSN
EEECCCCCCHHHHCC
48.4520167786
371AcetylationKTFWEKSNLTKHQRS
CCHHHHCCCCCCCCC
63.90-
383AcetylationQRSHTGEKPFECNEC
CCCCCCCCCEECCCC
57.2525443231
390UbiquitinationKPFECNECGKAFSHK
CCEECCCCCCCCCCC
4.16-
390AcetylationKPFECNECGKAFSHK
CCEECCCCCCCCCCC
4.16-
406PhosphorylationALTLHQRTHTGEKPY
CEEEECCCCCCCCCE
19.74-
408PhosphorylationTLHQRTHTGEKPYQC
EEECCCCCCCCCEEC
46.56-
418UbiquitinationKPYQCNACGKTFYQK
CCEECCCCCCEEECC
3.41-
434PhosphorylationDLTKHQRTHTGQKPY
CCCCCCCCCCCCCCE
19.7428258704
462PhosphorylationHLTVHQRTHTGEKPF
CEEEEECCCCCCCCE
19.74-
464PhosphorylationTVHQRTHTGEKPFEC
EEEECCCCCCCCEEH
46.56-
474UbiquitinationKPFECLECGKSFCQK
CCEEHHHCCHHHHHH
5.55-
546PhosphorylationDLTIHQRTHTGEKPF
CCEEEECCCCCCCCE
19.74-
548PhosphorylationTIHQRTHTGEKPFAC
EEEECCCCCCCCEEC
46.56-
574PhosphorylationTLSQHYRTHTGEKPY
HHHHHHHHCCCCCCE
19.34-
576PhosphorylationSQHYRTHTGEKPYEC
HHHHHHCCCCCCEEE
46.56-
591PhosphorylationHECGKIFYNKSYLTK
CCCCCEEECHHHHCC
25.75-
593SumoylationCGKIFYNKSYLTKHN
CCCEEECHHHHCCCC
29.15-
595PhosphorylationKIFYNKSYLTKHNRT
CEEECHHHHCCCCCC
21.72-
600SumoylationKSYLTKHNRTHTGEK
HHHHCCCCCCCCCCC
52.69-
602PhosphorylationYLTKHNRTHTGEKPY
HHCCCCCCCCCCCCC
29.1628348404
604PhosphorylationTKHNRTHTGEKPYEC
CCCCCCCCCCCCCCC
46.5629496963
614UbiquitinationKPYECNECGKTFCQK
CCCCCCCCCCCCCCH
4.16-
642UbiquitinationKPYECNECGKAFCHK
CCCCCCCCCCCEECC
4.16-
666SumoylationHTQEKPYKCNECGKS
CCCCCCCCCCCCCCE
38.83-
673SumoylationKCNECGKSFCVKSGL
CCCCCCCEEEEECCC
14.79-
673PhosphorylationKCNECGKSFCVKSGL
CCCCCCCEEEEECCC
14.7930108239
688PhosphorylationILHERKHTGEKPYEC
EEEECCCCCCCCEEC
50.5023532336
698UbiquitinationKPYECNECGKSFSHK
CCEECCCCCCCCCCC
5.31-
703PhosphorylationNECGKSFSHKSSLTV
CCCCCCCCCCCCCEE
36.78-
735UbiquitinationKIFYRKSDLAKHQRS
CEEEEHHHHHHHHHH
54.39-
761SumoylationCRKTFSQKSNLIVHQ
CCCCCCCCCCEEEEE
39.86-
768SumoylationKSNLIVHQRTHIGEK
CCCEEEEECCCCCCC
40.86-

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of ZN33B_HUMAN !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of ZN33B_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of ZN33B_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
HAP1_HUMANHAP1physical
15383276
ZHX1_HUMANZHX1physical
15383276

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of ZN33B_HUMAN

loading...

Related Literatures of Post-Translational Modification

TOP